Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
What Is A Stock Index Level
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesSmartest Vanguard with $500: A Practical Buy Guide
Starting with $500 can still build a solid foundation for long-term wealth. This guide reveals how to target the smar...
What This Filing Means: RPM's Record Q4 EBIT Surge
RPM International just posted a record Q4 EBIT across its segments. Alongside an insider Form 4 filing, this raises q...
Citi Latest Bank Sour on Super Micro Stock Sparks Caution
Citi has joined a growing chorus of concerns around Super Micro Computer, trimming its price target to $25 amid expor...
SpaceX Retail Surge Sparks a Two-Day Buy-In Record
Retail buyers piled into SpaceX shares over a two-day window, creating a record pace that outstripped every other U.S...
Short Sellers Targeting SoFi: Should You Panic Today?
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
What’s Wrong with Costco? Investors Weigh Growth and Risk
Costco reports solid membership-driven results in mid-2026, but the stock faces a high bar for growth and valuation. ...
Extra Space Storage (EXR) Earnings Deep Dive for Investors
Want to understand how Extra Space Storage (EXR) earns and how to read its earnings calls like a pro? This deep dive ...
Stock Market Today, March: Nokia Signals 5G Momentum
Nokia climbs on 5G demand and North American telecom spend, while broader markets drift. A practical look at what thi...
Is AMD Still a Buy After Nearly 300% Over Past Year?
AMD has delivered a staggering run, rising nearly 300% over past year. This article breaks down whether the momentum ...
Caterpillar Stock Nearing 52-Week High: Buy, Hold?
Caterpillar stock is edging toward its 52-week high as orders surge and the Power & Energy arm expands. Yet investors...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status